CCG is hosting a 1-day meeting focusing on benefits of computer-aided ligand and structure-based drug design techniques for medicinal chemists.
Short hands-on workshops in the morning will be followed by scientific presentations in the afternoon. The meeting will end with a social reception.
Please note that space is limited so early registration is recommended.
Michael Drummond, Scientific Applications Manager, CCG
Jonathan Grob, Scientist II, Novartis
Hakan Gunaydin, Principal Scientist, Relay Therapeutics
Torsten Herbertz, Director, Computational Chemistry, FORMA Therapeutics
Hui Huang, Senior Principal Scientist, Janssen
Frank Lovering, Director, Computational Chemistry, Pfizer
Paul Scola, Research Fellow, Bristol Myers Squibb
Gang Yao, Drug Design and Selection, Medicinal Science & Technology, GlaxoSmithKline
Registration (check-in and badge pick-up)
Pharmacophore Modeling / Docking / Fragment-based Design / Scaffold Replacement / R-Group Screening / Project Search / Protein-Ligand Interaction Fingerprints
R-Group Profiles and Analysis / MOEsaic / MMP Analysis / Descriptor Calculations / Conformational Searching / Molecular Alignments / Pharmacophore Modeling and Searching / Diversity Analysis
|13:00-13:30||Registration (check-in and badge pick-up)|
|13:35-14:05||Speaker to be announced|
|14:05-14:35||Speaker to be announced|
|14:35-15:05||Speaker to be announced|
|15:05-15:35||Speaker to be announced|
|16:05-16:35||Speaker to be announced|
|16:35-17:05||Speaker to be announced|
|17:05-17:35||Speaker to be announced|
|17:35-18:05||Speaker to be announced|
There is no cost to attend but pre-registration is required as seats are limited. Registrations will be processed and accepted on a first-come, first-serve basis.
Le Méridien Cambridge-MIT
- Alain Deschenes, Chemical Computing Group
- Matthieu Barragué, Sanofi
- Raul Alvarez, Chemical Computing Group
- Veerabahu (Veer) Shanmugasundaram, Celgene
20 Sidney Street
Cambridge, MA 02139